<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71466">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02175368</url>
  </required_header>
  <id_info>
    <org_study_id>AOFU 2012</org_study_id>
    <nct_id>NCT02175368</nct_id>
  </id_info>
  <brief_title>Adhese One F Upgrade in Direct Filling Therapy</brief_title>
  <official_title>Clinical Evaluation of AdheSE One F Upgrade in Direct Filling Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ivoclar Vivadent AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ivoclar Vivadent AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation on the clinical performance of a new dental adhesive when used in direct
      filling therapy after phosphoric acid etching.

      Hypothesis: The new adhesive shows an acceptable clinical performance and allows a good
      filling quality.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with clinical success</measure>
    <time_frame>1 week</time_frame>
    <description>Clinical success is defined as no postoperative hypersensitivity and no loss of the restoration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical quality</measure>
    <time_frame>1 week, 1 year, 2 years, 3 years</time_frame>
    <description>The clinical quality of the restorations will be evaluated according to semi-quantitative clinical evaluation (SQUACE) criteria and compared at all time points.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Dental Adhesive</condition>
  <arm_group>
    <arm_group_label>Adhese One F Upgrade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adhese One F Upgrade (AOFU) is administered after phosphoric acid etching (etch-and-rinse protocol).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adhese One F Upgrade</intervention_name>
    <arm_group_label>Adhese One F Upgrade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  indication for class I or II filling

          -  max. 2 restorations per patient

          -  vital teeth

          -  sufficient language skills

        Exclusion Criteria:

          -  dry working field cannot be established

          -  if the patient is known to be allergic to any of the materials` ingredients

          -  severe systemic diseases

          -  pregnancy

          -  non-vital or pulpitic teeth

          -  indication for indirect restoration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnd Peschke, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ivoclar Vivadent AG</affiliation>
  </overall_official>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 29, 2016</lastchanged_date>
  <firstreceived_date>June 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total etch protocol</keyword>
  <keyword>direct filling therapy</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
